论文信息 - Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study - 字舞流文

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study

J. Bourke | K. Bushby | F. Muntoni | K. Anthony | G. Dickson | V. Arechavala-Gomeza | K. Bushby | R. Kole | M. Wood | S. Wilton | D. Wells | S. Çırak | C. Sewry | V. Straub | M. Guglieri | S. Abbs | S. Torelli | J. Morgan | Lucy Feng | M. Garralda | S. Shrewsbury | J. Bourke | Dominic J. Wells | Matthew J Wood | M. Garralda | Katerine Bushby | Francesco Muntoni | Stephen Abbs | George Dickson | Matthew JA Wood | Dominic J Wells | Ryszard Kole | Volker Straub | Jennifer E Morgan | Karen Anthony | John Bourke | Steve D Wilton | Stephen B Shrewsbury | Dominic J. Wells | Caroline Sewry | Francesco Muntoni | Karen Anthony | John Bourke | Steve D Wilton | Stephen B Shrewsbury | Steve D. Wilton | Jennifer E. Morgan